FogPharma

Corporate brand

Parabilis Medicines is a clinical-stage biopharmaceutical company pioneering a new class of alpha-helical peptides called Helicons™ to target historically undruggable proteins.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines.

History

Parabilis Medicines is a clinical-stage biopharmaceutical company. It has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/fogpharma · Editorial policy · How profiles are compiled